Leukemia Program at Northside Hospital
Northside Hospital Cancer Institute has been named a 2026 top 50 US hospital for cancer care by US News & World Report and ranks in the top 6% of all US cancer programs.
All four Northside hospitals received a High Performing designation for the treatment of multiple myeloma, leukemia, and non-Hodgkin lymphoma patients.
NH-Leukemia program facts:
High survival rates as published in the 2026 US and World report data release.
All four Northside hospitals received a High Performing designation for the treatment of multiple myeloma, leukemia, and non-Hodgkin lymphoma.
Amongst the largest acute leukemia programs in the Southeast.
Annually treats over 300 new leukemia and hematological malignancy patients per year.
In-house NH Diagnostic Laboratory Testing:
NH Leukemia program is able to diagnose and initiate a treatment plan much faster than majority of US leukemia centers by having our own diagnostic facilities on site (flow, molecular, NGS sequencing, etc.) which leads to superior outcomes and reduced morbidities.
Leading-edge leukemia clinical research portfolio
Extensive peer-reviewed leukemia and hematological malignancy papers published.
Annually presents at the American Society of Hematology (ASH) meeting.
Only leukemia regional program (as well as transplant program) that has its own platelet donor blood program, Atlanta Blood Services, to support patients through treatment.
View Lou Cohen’s story below.
Early Donor Identification: Family HLA typing initiated early in the treatment phase allows early blood or marrow donor identification.
Blood and Marrow Transplant: Seamless and quick integration to the NH-BMT program.
Leukemia and BMT coordinators work collaboratively to ensure a smooth and quick transition to the NH BMT program.
The NH-BMT program is the only adult allogeneic BMT program in Georgia to achieve one-year survival outcomes that significantly exceed the expected range for the last 17 consecutive reporting cycles (2009-2025) [1, 2].
Dedicated leukemia/BMT teams who provides comprehensive, patient-centered care in a compassionate setting.
Oncology Business office supports transportation and housing assistance.
Highly trained, experienced, and dedicated Team.
1. For seventeen consecutive years (2009-2025), NH-BMT achieved survival outcomes that significantly exceed the expected range, as reported in the Center for International Blood and Marrow Transplant Research's Final 2025 Transplant Center Specific Survival Report, December 2025, and from reported outcome data from NMDP.org®.
2. There were 176 adult and pediatric transplant centers included in the analysis. This survival information includes only patients who received their first allogeneic transplant between January 1, 2021, and December 31, 2023, using unrelated or related donors, and who had reported follow-up. Specific transplant center information can be found at nmdp.org.
Lou Cohan’s journey with Northside Hospital has come full circle: his daughters and grandson were born there, and now he’s giving back as a platelet donor.
A single platelet donation can help up to three people. Inspired by a friend’s leukemia diagnosis, Lou has made nearly 250 donations over 30 years, potentially helping more than 700 patients. His story highlights the power of small acts to make a big difference, urging others to join his “250 for 250” campaign.
Through donating platelets, Lou shows how anyone can be a hero by giving the gift of time, life and hope.
There are heroes among us, everywhere. Arguably almost every mom and dad is a hero at some point, as we all sacrifice for our kids.
For me, donating blood and platelets is a huge opportunity to be a hero. I hope you will think so, too. I invest a few hours per month. In return, I maybe save or extend someone’s life. That’s a lot of leverage.